Found: 73
Select item for more details and to access through your institution.
Detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is influenced by the type of transport medium: Implications for diagnosis and monitoring.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 8, p. 1, doi. 10.1111/ijcp.14311
- By:
- Publication type:
- Article
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2018, v. 10, n. 1, p. 1, doi. 10.4084/MJHID.2018.002
- By:
- Publication type:
- Article
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 6, p. 462, doi. 10.1002/cyto.b.22099
- By:
- Publication type:
- Article
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B‐cell acute lymphoblastic leukemia using multicolor flow cytometry.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 3, p. 199, doi. 10.1002/cyto.b.22063
- By:
- Publication type:
- Article
Immunophenotypic shift in the B‐cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B‐lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 434, doi. 10.1002/cyto.b.21951
- By:
- Publication type:
- Article
Eleven‐marker 10‐color flow cytometric assessment of measurable residual disease for T‐cell acute lymphoblastic leukemia using an approach of exclusion.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 421, doi. 10.1002/cyto.b.21939
- By:
- Publication type:
- Article
Sudden blast phase in pediatric chronic myeloid leukemia‐chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 345, doi. 10.1002/cyto.b.21958
- By:
- Publication type:
- Article
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre‐myelomastocytic leukemia condition.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 331, doi. 10.1002/cyto.b.21938
- By:
- Publication type:
- Article
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 2, p. 206, doi. 10.1002/cyto.b.21943
- By:
- Publication type:
- Article
CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 4, p. 328, doi. 10.1002/cyto.b.21866
- By:
- Publication type:
- Article
A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10<sup>6</sup> and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 1, p. 57, doi. 10.1002/cyto.b.21831
- By:
- Publication type:
- Article
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 3, p. 509, doi. 10.1002/cyto.b.21619
- By:
- Publication type:
- Article
Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 100, doi. 10.1002/cyto.b.21486
- By:
- Publication type:
- Article
CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
- Published in:
- Cytometry. Part B, 2017, v. 92, n. 4, p. 315, doi. 10.1002/cyto.b.21373
- By:
- Publication type:
- Article
Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
- Published in:
- Cytometry. Part B, 2012, v. 82B, n. 4, p. 252, doi. 10.1002/cyto.b.21017
- By:
- Publication type:
- Article
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 1, p. 122, doi. 10.1111/ejh.14102
- By:
- Publication type:
- Article
Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with Chemotherapy.
- Published in:
- Indian Journal of Pediatrics, 2024, v. 91, n. 6, p. 564, doi. 10.1007/s12098-023-04689-4
- By:
- Publication type:
- Article
Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00577
- By:
- Publication type:
- Article
Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Standardization of High Sensitivity Minimal Residual Disease Monitoring in Multiple Myeloma: An Experience in Tertiary Cancer Centre.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e357, doi. 10.1016/j.clml.2019.09.590
- By:
- Publication type:
- Article
Prognostic Relevance of the Proportion of Residual Polyclonal Plasma Cells in the Diagnostic Bone Marrow of Newly Diagnosed Multiple Myeloma Patients Managed Without Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e238, doi. 10.1016/j.clml.2019.09.396
- By:
- Publication type:
- Article
Standardization of High Sensitivity Minimal Residual Disease Monitoring in Multiple Myeloma: An Experience in Tertiary Cancer Centre.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e183, doi. 10.1016/j.clml.2019.09.306
- By:
- Publication type:
- Article
Evaluation of CD319 (SLAMF7) as a Novel Gating Marker for Plasma Cells in Flow Cytometric Immunophenotyping of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e153, doi. 10.1016/j.clml.2019.09.255
- By:
- Publication type:
- Article
A Comprehensive Serum Microrna Profiling in Indian Multiple Myeloma Patients Uniformly Treated With VCD-Protocol.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e80, doi. 10.1016/j.clml.2019.09.127
- By:
- Publication type:
- Article
Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S282, doi. 10.1016/j.clml.2018.07.216
- By:
- Publication type:
- Article
Absolute Lymphocyte Count and Ratio of Absolute Lymphocyte Count/Absolute Monocyte Count (ALC/AMC) Provides a Readily Available Prognostic Indicator in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e101, doi. 10.1016/j.clml.2017.03.182
- By:
- Publication type:
- Article
SLAM Family Member “CD229”: A Novel Gating Marker for Plasma Cells in Flow Cytometric Immunophenotyping (FCI) of Multiple Myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e19, doi. 10.1016/j.clml.2017.03.032
- By:
- Publication type:
- Article
Synchronous Presentation of Smoldering Multiple Myeloma (SMM) and Polycythemia Vera (PV)-A Rare Case Report.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e151, doi. 10.1016/j.clml.2017.03.272
- By:
- Publication type:
- Article
Utility of the New Versus Old Immunophenotypic Markers in the Flow Cytometric Immunophenotyping of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e92, doi. 10.1016/j.clml.2017.03.165
- By:
- Publication type:
- Article
Flow Cytometric Immunophenotyping in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia Demonstrates Characteristic Antigen Expression Pattern.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e51, doi. 10.1016/j.clml.2017.03.093
- By:
- Publication type:
- Article
Role of Multicolor Flow Cytometry in Assessing Bone Marrow Involvement by Solitary Plasmacytoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e25, doi. 10.1016/j.clml.2017.03.043
- By:
- Publication type:
- Article
Mandatory preoperative COVID‐19 testing for cancer patients—Is it justified?
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 7, p. 1288, doi. 10.1002/jso.26187
- By:
- Publication type:
- Article
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Molecular basis of Wiskott- Aldrich syndrome in patients from India.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 356, doi. 10.1111/j.1600-0609.2012.01818.x
- By:
- Publication type:
- Article
Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1249, doi. 10.1111/bjh.19251
- By:
- Publication type:
- Article
United we stand, divided we fall. Multicentre standardization of measurable residual disease assessment in acute leukaemia is the way forward.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 3, p. 277, doi. 10.1111/bjh.18533
- By:
- Publication type:
- Article
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B‐lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 374, doi. 10.1111/bjh.17801
- By:
- Publication type:
- Article
KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 2, p. 1, doi. 10.1002/pbc.30791
- By:
- Publication type:
- Article
Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B‐ALL.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 10, p. 1, doi. 10.1002/pbc.29658
- By:
- Publication type:
- Article
A 3½-Year-Old Child With a Posterior Fossa Mass.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2006, v. 130, n. 4, p. 565, doi. 10.5858/2006-130-565-aycwap
- By:
- Publication type:
- Article
A 40-Year-Old Woman With Multiple Uterine Masses.
- Published in:
- 2005
- By:
- Publication type:
- Case Study
A novel and easy FxCycle ™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.
- Published in:
- Cytometry. Part A, 2016, v. 89, n. 3, p. 281, doi. 10.1002/cyto.a.22803
- By:
- Publication type:
- Article
Molecular MRD Assessment in Acute Myeloid Leukemias.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2023, v. 44, n. 6, p. 566, doi. 10.1055/s-0043-1762921
- By:
- Publication type:
- Article
Triple Trouble: Disseminated Penicilliosis in a Cancer patient with COVID-19.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2023, v. 44, n. 4, p. 445, doi. 10.1055/s-0042-1759505
- By:
- Publication type:
- Article
A Rare Extramedullary and Extralymphoid Presentation of Mixed Phenotypic Blastic Hematolymphoid Neoplasm: A Study of Two Cases.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2017, v. 38, n. 3, p. 394, doi. 10.4103/ijmpo.ijmpo_94_16
- By:
- Publication type:
- Article
Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 1, p. 99, doi. 10.1111/ajco.13522
- By:
- Publication type:
- Article
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 24, p. 8777, doi. 10.1002/cam4.4379
- By:
- Publication type:
- Article
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.
- Published in:
- Immunology & Cell Biology, 2022, v. 100, n. 1, p. 61, doi. 10.1111/imcb.12504
- By:
- Publication type:
- Article
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00450
- By:
- Publication type:
- Article